Speaker line-up of 2020
Abigail Herron
Global Head of Responsible Investment, Aviva Investors
Albina Poljak
Director Business Development, PhagoMed Biopharma GmbH
Aleksandar Danilovski
Chief Scientific Officer (CSO), Xelia Pharmaceuticals
Alexandra Cameron
Senior Technical Manager, Strategy Team, Unitaid
Anand Anandkumar
Chief Executive Officer, Bugworks Research Inc.
Anita Suresh
Head of Sequencing Programme, Foundation for Innovative New Diagnostics (FIND)
Bruce Altevogt
Vice President and Head External Medical Engagement, Hospital Business Unit at Pfizer
Catharina Boehme
CEO, FIND (Foundation for Innovative New Diagnostics)
Cecilia Ferreyra
AMR programme lead, FIND (Foundation for Innovative New Diagnostics)
Cesar de la Fuente
Presidential Assistant Professor, University of Pennsylvania
Cherif Bousselham
Senior Vice President, Head of Sales, EMEA, Accelerate Diagnostics
Claudia Maria Denkinger
Head of Division of Tropical Medicine, University Hospital Heidelberg
Claus Stie Kallesøe
CEO and Co-Founder, grit42
Colm Leonard
Consultant Clinical Adviser/Consultant Thoracic Physician/Honorary Professor of Respiratory Medicine, National Institute of Health and Care Excellence UK & Manchester University NHS Foundation Trust
Dame Sally Davies
UK Special Envoy on Antimicrobial Resistance, UK Department of Health and Social Care
Daniel Berman
Lead of the Global Health Team, Longitude Prize / Nesta
Dave Madge
Vice President, Research Service Division, WuXi AppTec
Deborah O’Neil
CEO, NovaBiotics Ltd & Board Member, BEAM Alliance
Dirk Bumann
Infection biologist, University of Basel - Biozentrum
Douglas Kwon
Scientific Co-Founder & Associate Professor, Harvard Medical School
Elmar Nimmesgern
Secretariat Lead, Global AMR R&D Hub
Erin Duffy
Chief of Research & Development, CARB-X
Florence Séjourné
CEO of Da Volterra & President of the BEAM Alliance
Gemma Buckland Merrett
Science and Research lead for the Drug Resistant Infections Priority Programme, Wellcome Trust
Ghada Zoubiane
Head of Partnerships and Stakeholder Engagement, ICARS
Gökhan Batur
CEO, Polyphor Ltd
Heiman Wertheim
Clinical Microbiologist, Radboud University Medical Center
Hosny Hassan El-Adawy
Head of National Reference Laboratory for Campylobacteriosis and National Reference Laboratory for Bovine Genital Campylobacteriosis, Friedrich-Loeffler-Institut (FLI)
Igor Orshanskiy
Director, Business Development & Alliance Management, AiCuris Anti-infective Cures GmbH
Irene Wüthrich
Co-founder, SpheroBiotics
James Anderson
Head of Corporate Government Affairs, GSK
Jean-Pierre Paccaud
Director of Business Development and Corporate Strategy, GARDP
Joe Fitchett
Medical Director, Mologic
Jonathan Butcher
Head of BD and Alliance Management, BioVersys AG
Kamini Walia
Head of AMR, ICMR, Government of India
Kathy Talkington
Director, Health Programs, The Pew Charitable Trusts
Kenneth Bradley
Global Head, Infectious Diseases Discovery Immunology, Infectious Diseases and Ophthalmology, Roche Pharma Research & Early Development (pRED) Roche Innovation Center Basel
Kevin Outterson
Austin B Fletcher Professor, Boston University, and Executive Director & Principal Investigator, CARB-X
Kwangmin Son
Co-founder and CEO, PHAST Corp.
Laurenz Kellenberger
CSO, Basilea Pharmaceutica Int. Ltd.
Mai Huong Chatain and Christophe Chatain
President & Scientific Director, Vetophage; Executive Assistant & Sales Manager, Vetophage
Manica Balasegaram
Executive Director for the Global Antibiotic R&D Partnership (GARDP)
Marc Lemonnier
Founding CEO, Antabio SAS
Michael Lobritz
Translational Project Leader, Roche
Michel Pieren
Project Manager, BioVersys AG
Nadine Taudte
Head of Laboratory/Senior scientist, PerioTrap Pharmaceuticals GmbH
Neciah Dorh
CEO, FluoretIQ
Niamh Máire Mohan
Pre-Clinical Technologist, Nuritas Ltd
Patrick Velicitat
Chief Medical Officer, Allecra Therapeutics, Saint Louis France
Peers Davies
Senior Lecturer in Livestock Health and Welfare Epidemiology and Population Health, University of Liverpool, CEIDR
Peter Beyer
Unit Head, Impact Initiatives and Research Coordination, AMR Division
Peter Warn
Consultant, Magic Bullet Consulting
Philippe Cleuziat
Senior Director, Open Innovation & Partnerships, bioMérieux
Rafael Canton
Head of Clinical Microbiology Department, Servicio de Microbiología. Hospital Universitario Ramón y Cajal-IRYCIS
Richard Knight
Director & Co-founder, ApconiX
Samareh Azeredo da Silveira Lajaunias
Founding Partner and General Manager, Combioxin SA
Sarah Paulin
Technical Officer in Antimicrobial Resistance, World Health Organization
Seamus O’Brien
R&D Director, GARDP
Sebastian Dümcke
CEO, Clemedi AG
Sergio Carmona
Chief Access Officer, FIND (Foundation for Innovative New Diagnostics)
Silas Holland
Head of External Affairs, AMR Action Fund
Stefanie Deinhardt-Emmer
Resident in Medical Microbiology, Institute of Medical Microbiology, Jena University Hospital
Sumathi Nambiar
Director Division of Anti-Infective Products, Office of Infectious Diseases, FDA
Suzanne Edwards
Scientific Programme Manager / Economist, Global AMR R&D Hub
Sven Hobbie
CEO, Juvabis AG
Thomas Hesterkamp
Head Translational Project Management Office (TPMO) Helmholtz-Zentrum für Infektionsforschung (HZI) and Deutsches Zentrum für Infektionsforschung (DZIF); CEO Myxobiotics
Tiemo Wölken
Member of the European Parliament
Till Bachmann
Deputy Head of Infection Medicine & Personal Chair of Molecular Diagnostics and Infection, University of Edinburgh
Till Schäberle
Professor, Head of Natural Product Research at University of Gießen & Fraunhofer Institute for Molecular Biology and Applied Ecology (IME); Deutsches Zentrum für Infektionsforschung (DZIF)
Tim Jinks
Head of Antibiotic Resistance Infections Program, Wellcome Trust
Timo Minssen
Founder and Managing Director, Center for Advanced Studies in Biomedical Innovation Law (CeBIL)
Timothy Schulz-Utermoehl
Co-Founder and Director, Pedanius Therapeutics
Ursula Theuretzbacher
Founder, CEFAIA
Uzma Choudry
VC Investor, Octopus Ventures
Viviana Muñoz-Tellez
Coordinator, Development, Innovation and Intellectual Property Programme (DIIP), South-Center